Affinity DataIC50: 0.877nMAssay Description:Inhibition of human SGLT2More data for this Ligand-Target Pair
Affinity DataIC50: 0.877nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as inhibition of methyl alpha-D-glucopyranoside uptake after 1 hrMore data for this Ligand-Target Pair
Affinity DataIC50: 1.15nMAssay Description:Inhibition of rat SGLT2More data for this Ligand-Target Pair
Affinity DataIC50: 2.40nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as decrease in uptake of [14C]AMG after 120 mins by TopCount methodMore data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Haisco Pharmaceuticals Group Co. Ltd.
Curated by ChEMBL
Haisco Pharmaceuticals Group Co. Ltd.
Curated by ChEMBL
Affinity DataIC50: 392nMAssay Description:Inhibition of human SGLT1 expressed in CHO cells assessed as decrease in uptake of [14C]AMG after 120 mins by TopCount methodMore data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Haisco Pharmaceuticals Group Co. Ltd.
Curated by ChEMBL
Haisco Pharmaceuticals Group Co. Ltd.
Curated by ChEMBL
Affinity DataIC50: 1.96E+3nMAssay Description:Inhibition of human SGLT1More data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 1(Homo sapiens (Human))
Haisco Pharmaceuticals Group Co. Ltd.
Curated by ChEMBL
Haisco Pharmaceuticals Group Co. Ltd.
Curated by ChEMBL
Affinity DataIC50: 1.96E+3nMAssay Description:Inhibition of human SGLT1 expressed in CHO cells assessed as inhibition of methyl alpha-D-glucopyranoside uptake after 1 hrMore data for this Ligand-Target Pair
